Home > Medicine > Clinical & internal medicine > Rheumatology > Clinical Tuberculosis Diagnosis & Treatment
27%
Clinical Tuberculosis Diagnosis & Treatment

Clinical Tuberculosis Diagnosis & Treatment

          
5
4
3
2
1

Available


Premium quality
Premium quality
Bookswagon upholds the quality by delivering untarnished books. Quality, services and satisfaction are everything for us!
Easy Return
Easy return
Not satisfied with this product! Keep it in original condition and packaging to avail easy return policy.
Certified product
Certified product
First impression is the last impression! Address the book’s certification page, ISBN, publisher’s name, copyright page and print quality.
Secure Checkout
Secure checkout
Security at its finest! Login, browse, purchase and pay, every step is safe and secured.
Money back guarantee
Money-back guarantee:
It’s all about customers! For any kind of bad experience with the product, get your actual amount back after returning the product.
On time delivery
On-time delivery
At your doorstep on time! Get this book delivered without any delay.
Add to Wishlist

About the Book

• Written for defining a practical approach to every aspect of tuberculosis in 50 chapters.
• Covers all the aspects of tuberculosis ranging from epidemiology, diagnosis, practical approach to the treatment of pulmonary as well as common extra-pulmonary tuberculosis including HIV.
• Explains practical approach to MDR-TB and XDR-TB.
• Covers chapters on prevention & control of TB in India.
• Pharmacokinetics of anti-tuberculosis including doses, regimens, adverse effects has been highlighted.
• Special chapters on case-based approach to treatment of tuberculosis in special situation.
• Chapters on TB in children, TB in elderly, non-tuberculous mycobacteria and infection control in TB are also included.
• Chapters have been written in the background of current literature and practical experience gained from day-to-day dealing with different patients suffering from tuberculosis.
• Undergraduate, postgraduate medical students, practitioners and program managers in TB control will find this book a practical guide.

About the Author

Rajendra Prasad MD DTCD FAMS FCCP (USA) FNCCP FCAI FIAB FIMSA DSC (Honoris Causa) Nikhil Gupta MD



Table of Contents:
1. Landmarks in Tuberculosis Treatment 1 2. Case Definitions in Tuberculosis 8 • Case Definitions 8 • Disease Classification 9 • Types of Tuberculosis Patients 11 • Directly Observed Treatment 11 • Directly Observed Treatment Plus 12 • Treatment Outcomes of DOTS 12 • Drug Resistant Tuberculosis 13 • Treatment Outcomes in DOTS-Plus 14 • HIV Setting Case Definitions 16 3. Epidemiology of Tuberculosis 18 • Epidemiological Indices 18 • Global Burden of Tuberculosis 22 • Tuberculosis Burden in India 24 4. Clinical Presentation of Tuberculosis 33 • Congenital Tuberculosis 33 • Primary Tuberculosis 34 • Post-primary Tuberculosis 39 5. Miliary Tuberculosis 47 • Pathogenesis 47 • Pathology 48 • Diagnosis 49 • Treatment 50 • Complications 50 6. Endobronchial Tuberculosis 52 • Epidemiology 52 • Pathophysiology 53xiv Clinical Tuberculosis: Diagnosis and Treatment • Natural History 54 • Diagnosis 55 • Differential Diagnosis 59 • Treatment 60 • Endobronchial Tuberculosis in Special Situations 61 7. Lower Lung Field Tuberculosis 69 • Definition 69 • Prevalence 70 • Pathogenesis 70 • Clinical Features 70 • Investigations 71 • Associated Medical Conditions 74 • Management 74 8. Hemoptysis 77 • Pseudo or Spurious Hemoptysis 78 • Grades of Hemoptysis 78 • Recurrent Hemoptysis 78 • Etiology of Hemoptysis 78 • Hemoptysis with Normal Chest X-ray 80 • Mechanism of Bleeding 80 • Pathogenesis of Hemoptysis in Tuberculosis 81 • Diagnosis of Hemoptysis 81 • Treatment of Hemoptysis 85 9. Diagnostic Techniques in Tuberculosis 90 9A: Diagnosis of Latent Tuberculosis Infection 90 • Tuberculin Skin Test 90 • Interferon-g Assays 94 9B: Radiology 97 • Imaging Modalities 97 • Imaging in Pulmonary Tuberculosis 97 • Sequelae and Complications of Tuberculosis 106 • Radiographic Follow-up Schedule 107 9C: Bacteriology 109 • Direct Demonstration by Staining Technique 109 • Mycobacterial Culture in the Diagnosis of Tuberculosis 110 • Drug Susceptibility Testing 113 • Newer Tools Under Development 115 9D: Histopathology 119 9E: Polymerase Chain Reaction (PCR) 121 9F: Serology 124 • Antibody-based Tests 124 • Antigen-based Tests 128 • Serology in Diagnosing Pulmonary TB in Patients with HIV Infection 129Contents xv • RoleofSerologyinDiagnosingTuberculosisinChildren 130 • Role of Serology in Diagnosing Extrapulmonary TB 130 9G: Fiberoptic Bronchoscopy 134 • Indications 134 • Specimen Collected 134 • Result 135 • Precautions 136 • Drawback 136 9H: Others 138 • Fine Needle Aspiration Cytology 138 • Radioactive Bromide Particles Test 138 • Adenosine Deaminase Assay 138 • Tuberculostearic Acid Estimation 138 10. Differential Diagnosis of Pulmonary Tuberculosis 140 • Pneumonia 140 • Fungal Diseases 141 • Parasitic Disease 142 • Bronchiectasis 143 • Lung Abscess 144 • Allergic Bronchopulmonary Aspergillosis 145 • Pulmonary Edema 147 • Lung Cancer 147 • Sarcoidosis 152 • Occupational Lung Diseases 154 • Pulmonary Infarction 154 • Congenital Conditions 154 • Cardiovascular Diseases 154 11. Complications of Tuberculosis 156 • Hemoptysis 156 • Fungus Ball 157 • Bronchiectasis 159 • Tuberculosis Endobronchitis and Tracheitis 159 • Spontaneous Pneumothorax 160 • Calcification 160 • Tuberculous Laryngitis 160 • Tuberculous Enteritis 161 • Open Negative Syndrome 161 • Scar Carcinoma 162 • Physiological Changes 162 • Amyloidosis 163 • Chronic Respiratory Failure 164 • Chronic Cor Pulmonale 164xvi Clinical Tuberculosis: Diagnosis and Treatment 12. Post-tubercular Obstructive Airway Impairment 169 • Pathophysiology 169 • Diagnosis 171 • Treatment 172 13. Antitubercular Drugs Used in Newly Diagnosed Patients of Tuberculosis and their Adverse Effects 174 • Isoniazid 174 • Rifampicin 178 • Ethambutol 180 • Pyrazinamide 181 • Streptomycin 183 • Thioacetazone 184 • Management of Common Adverse Effect 185 14. Antitubercular Drug Used in Previously Treated Patients of Tuberculosis and their Adverse Effect 189 • Kanamycin 189 • Amikacin 194 • Capreomycin 200 • Ethionamide and Prothionamide 202 • Cycloserine 205 • Para-aminosalicylic Acid (PAS) 208 • Levofloxacin 210 • Moxifloxacin 212 • Ofloxacin 215 • Clofazimine 217 • Thiacetazone 218 • Clarithromycin 219 • Linezolid 221 • Imipenem/Cilastatin 222 • Amoxicillin Clavulanate 223 15. How Does Tuberculosis Treatment Work? 225 • Bacteriological Factors 225 • Environmental Factors 226 • Pharmacological Factors 227 16. Basic Concepts in Treatment of Tuberculosis 229 • Role of Special Diet and Rest 229 • Role of Hospitalization 230 • Single Drug Therapy versus Multiple Drugs 230 • Single versus Divided Doses 230 • Optimum Duration of Treatment 231 • Fixed Dose Combinations (FDCs) versus Separate Drugs 231Contents xvii • Daily versus Intermittent Therapy 233 • Monitoring of Progress of Chemotherapy 234 • Causes of Failure of Chemotherapy 235 • Role of Surgery in Pulmonary Tuberculosis 236 17. Anti-tubercular Drug Doses and Regimens for Adults and Children 240 18. Duration of Treatment in Tuberculosis 245 • Sputum Positive Pulmonary Tuberculosis 245 • Sputum Smear-negative Pulmonary Tuberculosis 245 • Standard Conventional Long-term Nonrifampicincontaining Regimen 245 19. Treatment of Tuberculosis in Special Conditions— Pregnancy, Liver and Renal Disease 248 • Pharmacokinetics of Antitubercular Drugs 248 • Treatment of Tuberculosis in Pregnancy and Lactation 250 • Treatment of Tuberculosis in Renal Insufficiency 251 • Treatment of Tuberculosis in Liver Diseases 254 20. Treatment of Tuberculosis in Special Conditions—Pregnancy, Liver and Renal Diseases—Case-based Approach 259 • Treatment of Tuberculosis in Pregnancy and Lactation 259 • Treatment of Tuberculosis in Renal Insufficiency 260 • Treatment of Tuberculosis in Liver Disease 261 21. Treatment of Extrapulmonary Tuberculosis 263 • Tuberculous Lymphadenitis 264 • Pleural Effusion 265 • Tuberculous Meningitis (TBM) 266 • Bone and Joint Tuberculosis 267 • Miliary Tuberculosis 268 • Tuberculous Pericarditis 269 • Abdominal Tuberculosis 269 • Genitourinary Tuberculosis 270 • Ocular Tuberculosis 270 • Upper Respiratory Tract Tuberculosis 271 • Cutaneous Tuberculosis 271 22. Corticosteroids in Tuberculosis 276 • Indications of Corticosteroids in Tuberculosis 276 • Dose and Duration of Corticosteroids 281xviii Clinical Tuberculosis: Diagnosis and Treatment 23. Management of Retreatment Cases in Tuberculosis 284 • Relapse 284 • Defaulters or Treatment after Default 285 • Failure 286 • Poor Adherence to Treatment 286 • Drug Resistant Tuberculosis 287 • Prevention of Retreatment Cases 293 24. Drug Resistant and Multidrug Resistant Tuberculosis: Current Status 297 • Definition 297 • Types of Drug Resistance 298 • Prevalence of MDR-TB: Global 298 • Trends in MDR-TB: Global 302 • Prevalence of MDR-TB: India 303 • HIV Infection and Multidrug Resistant Tuberculosis 306 • Risk Factors of MDR-TB 308 • Sources and Causes of MDR-TB 308 • Control of MDR-TB 309 25. Drug Resistant and Multidrug Resistant Tuberculosis: Management 313 • Definition 313 • Mechanism of Drug Resistance 313 • Genetic Basis of Drug Resistance 314 • Virulence and Drug-resistant Strains 314 • Impact of Drug Resistance on the Outcome of Chemotherapy 315 • Diagnosis of Drug Resistant and Multidrug Resistant Tuberculosis 315 • Treatment of Drug Resistant and Multidrug Resistant Tuberculosis 319 • Outcome of Treatment 329 26. Multidrug Resistant Tuberculosis: Case-based Management 335 • Case I 335 • CASE II 337 • CASE III 337 • CASE IV 340 • CASE V 340 • CASE VI 343Contents xix 27. Multidrug Resistant Tuberculosis—Monitoring of Treatment and Adverse Drug Reaction 345 • Pretreatment Screening and Evaluation 345 • Monitoring Progress of Treatment 345 • Monitoring for Adverse Effects During Treatment 347 • Management of Adverse Effects 348 28. Multidrug Resistant Tuberculosis—Management in Special Situation 354 • M/XDR-TB in Pregnancy 354 • M/XDR-TB in Breastfeeding 355 • M/XDR-TB in Contraception 356 • M/XDR-TB in Children 356 • M/XDR-TB in Diabetes Mellitus 358 • M/XDR-TB in Renal Insufficiency 358 • M/XDR-TB in Liver Disorders 358 • M/XDR-TB in Seizure Disorders 359 • M/XDR-TB in Substance Dependence 360 • M/XDR-TB in Patients with Psychosis 360 29. Multidrug Resistant Tuberculosis Contacts: Management 363 • Management of Symptomatic Adult 363 • Contacts of Patients with MDR-TB 363 • Management of Symptomatic Pediatric 364 • Contacts of Patients with MDR-TB 364 • Chemoprophylaxis of Contacts of DR-TB Index Cases 365 30. Multidrug Resistant and Extensively Drug Resistant Tuberculosis: Prevention 367 • General Guidelines for the Prevention of MDR- and XDR-TB 368 31. Extensively Drug Resistant Tuberculosis: Current Status and Management 374 • Definition 374 • Epidemiology 375 • Factors Responsible for XDR-TB 377 • Diagnosis 377 • Treatment 378 • Monitoring of Treatment 380 • Outcomes of Treatment 381 • Role of Surgery 382 • HIV and XDR-TB 382 • XDR-TB in Pediatric Patients 383 • XDR-TB in Pregnancy 384xx Clinical Tuberculosis: Diagnosis and Treatment • WHO Response Strategies for XDR-TB Control of XDR-TB 386 32. Bacillus Calmette-Guerin (BCG) 390 • Basis of Giving BCG 390 • Types of BCG Vaccine 391 • Dose and Site of Vaccination 391 • Routes of Vaccination 391 • Efficacy and Safety 391 • Contraindications to BCG Vaccination 392 • Normal Reaction after BCG Vaccination 392 • Complications 393 • Various Strategies for the Development of Newer Tuberculosis Vaccines 396 33. Chemoprophylaxis in Tuberculosis 402 • Chemoprophylaxis in Tuberculosis 402 • Treatment Regimens and Duration 404 • Chemoprophylaxis Under Revised National Tuberculosis Control Program 404 • Chemoprophylaxis for Drug Resistant Tuberculosis 405 • Limitations of Chemoprophylaxis 405 • Place of Secondary Chemoprophylaxis in Tuberculosis Control 405 34. Tuberculosis Control in India: DOTS 408 • Landmarks of Tuberculosis Control in India 409 • Revised National Tuberculosis Control Program Strategy 411 • Revised National Tuberculosis Control Program Structure 412 • Diagnosis Under Revised National Tuberculosis Control Program (RNTCP) 412 • Treatment Regimen Used in Revised National Tuberculosis Control Program (RNTCP) 415 • Achievements of Revised National Tuberculosis Control Program 420 • Others Priority Initiatives in Revised National Tuberculosis Control Program 421 • Impact of Revised National Tuberculosis Control Program 424 • Challenges for Revised National Tuberculosis Control Program 424 • Problems of Revised National Tuberculosis Control Program 425 35. Tuberculosis Control in India: DOTS Plus 427 • Framework 427 • Case Finding Strategy 428Contents xxi • Enrolment into DOTS-Plus Program 429 • Confirmed MDR-TB Case 430 • Drug Resistant Tuberculosis Center 431 • Pre-treatment Evaluation 432 • Counseling 432 • Monitoring Progress During Treatment 433 • Category IV Regimen 434 • Drug Dosages and Administration 434 • Treatment Duration 435 • Regimen for XDR-TB 436 • Duration of Regimen for XDR-TB 436 • Treatment Interruption and Default 437 • Treatment Outcomes 438 • Providing Patient and Family Counseling 439 • Monitoring for Early Detection of Adverse Reactions 440 • Role of DR-TB Committee in the 440 • Management of Adverse Reactions 440 • Adherence 441 • Follow-up of the Non-adherent Patient 441 • DOTS-Plus Plan 442 36. Tuberculosis and HIV 444 • Epidemiology 444 • Impact of HIV on Tuberculosis 445 • Impact of Tuberculosis on HIV 446 • Diagnostic Difficulties in Persons with HIV/TB 446 • Coinfection 446 • Revised WHO Clinical Staging of HIV/AIDS for Adults and Adolescents with Confirmed HIV Infection 446 • Diagnosis of Pulmonary Tuberculosis 448 • Extrapulmonary Tuberculosis 450 • Investigations 452 • Treatment of Tuberculosis in HIV Positive Patients 454 • Adjuvant Corticosteroids in Extrapulmonary TB 455 • Highly Active Antiretroviral Therapy 455 • Interactions of Antituberculosis 456 • Therapy and Antiretroviral Therapy 456 • Immune Reconstitution Syndrome 458 • HIV and Drug Resistant TB Drug Interactions of Second Line Drugs and ART 459 • Recurrence of Tuberculosis after Completion of Tuberculosis Treatment 460 • Treatment of TB and HIV—WHO Recommended Collaborative TB/HIV Activities 460xxii Clinical Tuberculosis: Diagnosis and Treatment 37. Interaction between Antitubercular and Antiretroviral Drugs 465 • Antiretroviral Therapy for the Treatment of HIV Infection 465 • Pharmacokinetic Issues in the Treatment of HIV-related Tuberculosis 469 • Interaction between Antiretroviral and Antitubercular Drugs 469 • Drug-Drug Interactions in the Treatment of HIV and Drug Resistant-TB (DR-TB) 471 38. Tuberculosis and Diabetes 473 • Epidemiology 473 • Effect of Diabetes on Pulmonary Tuberculosis 474 • Effect of Pulmonary Tuberculosis on Diabetes 475 • Clinical Features and Course of Tuberculosis in Diabetics 475 • Roentgenographic Aspects of Tuberculosis in Diabetics 476 • Multidrug Resistant Tuberculosis (MDR-TB) and Diabetes 477 • Effect of Antituberculosis Drugs on Blood 477 • Glucose Level and OHA in Tubercular Diabetics 477 • Principles of Management 477 39. Tuberculosis and Pregnancy 480 • Effect of Pregnancy on Tuberculosis 480 • Effect of Tuberculosis on Pregnancy and Childbirth 481 • Diagnosis of Tuberculosis in Pregnant Woman 481 • Treatment of Pregnant Woman with Active Tuberculosis 482 • Treatment of Tuberculosis in Lactating Woman 483 • Isoniazid Prophylaxis in Pregnant Woman 484 • Isoniazid Prophylaxis for Infant Born to Woman with Active Tuberculosis 484 40. Tubercular Pleural Effusion 487 • Epidemiology 487 • Pathogenesis 487 • Clinical Manifestations 488 • Clinical Manifestations in HIV Positive Patients 489 • Diagnosis 489 • Natural History of Untreated Tuberculous Effusion 496 • Treatment 496 • Response to Treatment 498 41. Tubercular Empyema 504 • Etiopathogenesis 504 • Clinical Features 505Contents xxiii • Diagnosis 506 • Treatment 506 42. Tubercular Lymphadenitis 511 • Epidemiology 511 • Pathogenesis 512 • Clinical Features 512 • Diagnosis 513 • Treatment 515 43. Tuberculosis in Children 518 • Epidemiology 518 • Clinical Presentation of Tuberculosis 520 • Postprimary Extrapulmonary Tuberculosis 520 • Diagnosis of Childhood Tuberculosis 520 • Treatment of Tuberculosis in Children 522 44. Tuberculosis in Elderly 527 • Epidemiology 527 • Reasons for Reactivation 528 • Clinical Features 528 • Diagnosis 530 • Investigations in Tuberculosis in Elderly 530 • Treatment 531 45. Tuberculosis Abdomen 533 • Pathogenesis 533 • Clinical Features 534 • Investigations 538 • Treatment of Abdominal Tuberculosis 543 46. Tuberculosis of Kidney and Urinary Tract 547 • Epidemiology 547 • Pathophysiology 548 • Clinical Features 548 • Diagnosis of Tuberculosis of Kidney and Urinary Tract 551 • Treatment 556 47. Genitourinary Tuberculosis in Male 559 • Epidemiology 559 • Pathogenesis 559 • Clinical Features 560 • Investigations 561 • Treatment 563 48. Genitourinary Tuberculosis in Female 566 • Epidimiology 566xxiv Clinical Tuberculosis: Diagnosis and Treatment • Pathogenesis 567 • Clinical Presentation of Female Genital Tuberculoisis 568 • Diagnosis 568 • Treatment 571 49. Non-tubercular Mycobacteria 573 • Epidemiology 573 • Mode of Infections 574 • Classifications of NTM 575 • Distribution 576 • Clinical Presentations 576 • Diagnosis 577 • Features of NTM 580 • Treatment 582 50. Infection Control in Tuberculosis 587 • Mode of Infection in Tuberculosis 587 • The Difference between TB Infection and TB Disease 588 • Standard Precautions 589 • Hierarchy of Infection Control to Reduce Risk of Transmission of Respiratory Pathogens 589 • Managerial Activities for National, State, Hospital Administration, and Local Health Officials 590 • Administrative Control Strategies for Healthcare Facilities 591 • Environmental Control Measures 594 • Protection of Healthcare Workers and Staff 595 • Multidrug Resistant TB 596 • Drug Rehabilitation Centers and Corelations Institutions 597 Index 599


Best Sellers



Product Details
  • ISBN-13: 9789351522218
  • Publisher: Jaypee Brothers,medical Publishers Pvt. Ltd.
  • Publisher Imprint: Jaypee
  • Edition: 1
  • Language: English
  • Weight: 855 gr
  • ISBN-10: 9351522210
  • Publisher Date: 2015
  • Binding: Paperback
  • Height: 241 mm
  • No of Pages: 644
  • Width: 159 mm


Similar Products

Add Photo
Add Photo

Customer Reviews

REVIEWS           
Click Here To Be The First to Review this Product
Clinical Tuberculosis Diagnosis & Treatment
Jaypee Brothers,medical Publishers Pvt. Ltd. -
Clinical Tuberculosis Diagnosis & Treatment
Writing guidlines
We want to publish your review, so please:
  • keep your review on the product. Review's that defame author's character will be rejected.
  • Keep your review focused on the product.
  • Avoid writing about customer service. contact us instead if you have issue requiring immediate attention.
  • Refrain from mentioning competitors or the specific price you paid for the product.
  • Do not include any personally identifiable information, such as full names.

Clinical Tuberculosis Diagnosis & Treatment

Required fields are marked with *

Review Title*
Review
    Add Photo Add up to 6 photos
    Would you recommend this product to a friend?
    Tag this Book
    Read more
    Does your review contain spoilers?
    What type of reader best describes you?
    I agree to the terms & conditions
    You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.

    CUSTOMER RATINGS AND REVIEWS AND QUESTIONS AND ANSWERS TERMS OF USE

    These Terms of Use govern your conduct associated with the Customer Ratings and Reviews and/or Questions and Answers service offered by Bookswagon (the "CRR Service").


    By submitting any content to Bookswagon, you guarantee that:
    • You are the sole author and owner of the intellectual property rights in the content;
    • All "moral rights" that you may have in such content have been voluntarily waived by you;
    • All content that you post is accurate;
    • You are at least 13 years old;
    • Use of the content you supply does not violate these Terms of Use and will not cause injury to any person or entity.
    You further agree that you may not submit any content:
    • That is known by you to be false, inaccurate or misleading;
    • That infringes any third party's copyright, patent, trademark, trade secret or other proprietary rights or rights of publicity or privacy;
    • That violates any law, statute, ordinance or regulation (including, but not limited to, those governing, consumer protection, unfair competition, anti-discrimination or false advertising);
    • That is, or may reasonably be considered to be, defamatory, libelous, hateful, racially or religiously biased or offensive, unlawfully threatening or unlawfully harassing to any individual, partnership or corporation;
    • For which you were compensated or granted any consideration by any unapproved third party;
    • That includes any information that references other websites, addresses, email addresses, contact information or phone numbers;
    • That contains any computer viruses, worms or other potentially damaging computer programs or files.
    You agree to indemnify and hold Bookswagon (and its officers, directors, agents, subsidiaries, joint ventures, employees and third-party service providers, including but not limited to Bazaarvoice, Inc.), harmless from all claims, demands, and damages (actual and consequential) of every kind and nature, known and unknown including reasonable attorneys' fees, arising out of a breach of your representations and warranties set forth above, or your violation of any law or the rights of a third party.


    For any content that you submit, you grant Bookswagon a perpetual, irrevocable, royalty-free, transferable right and license to use, copy, modify, delete in its entirety, adapt, publish, translate, create derivative works from and/or sell, transfer, and/or distribute such content and/or incorporate such content into any form, medium or technology throughout the world without compensation to you. Additionally,  Bookswagon may transfer or share any personal information that you submit with its third-party service providers, including but not limited to Bazaarvoice, Inc. in accordance with  Privacy Policy


    All content that you submit may be used at Bookswagon's sole discretion. Bookswagon reserves the right to change, condense, withhold publication, remove or delete any content on Bookswagon's website that Bookswagon deems, in its sole discretion, to violate the content guidelines or any other provision of these Terms of Use.  Bookswagon does not guarantee that you will have any recourse through Bookswagon to edit or delete any content you have submitted. Ratings and written comments are generally posted within two to four business days. However, Bookswagon reserves the right to remove or to refuse to post any submission to the extent authorized by law. You acknowledge that you, not Bookswagon, are responsible for the contents of your submission. None of the content that you submit shall be subject to any obligation of confidence on the part of Bookswagon, its agents, subsidiaries, affiliates, partners or third party service providers (including but not limited to Bazaarvoice, Inc.)and their respective directors, officers and employees.

    Accept

    New Arrivals



    Inspired by your browsing history


    Your review has been submitted!

    You've already reviewed this product!